AxoGen (NasdaqCM:AXGN) Q4 2025 Earnings call February 24, 2026 08:00 AM ET Company ParticipantsCaitlin Roberts - DirectorJayson Bedford - Managing DirectorJens Schoener - CMOLindsey Hartley - CFOMichael Dale - CEORick Ditto - Medical Device & Life Science ExecutiveSimran Kaur - VPConference Call ParticipantsAnthony Petrone - Managing Director, Senior Medical Devices, Diagnostics and Therapeutics Equity Research AnalystChris Pasquale - Senior AnalystFrank Takkinen - Senior Research AnalystMichael Sarcone - A ...